Clinical utility of pleural fluid interferon-gamma release assay in tuberculous pleurisy diagnosis Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections Year: 2017
Pleural fluid interleukin-10 level in the diagnosis of tuberculous effusions Source: Eur Respir J 2002; 20: Suppl. 38, 581s Year: 2002
Comparison of diagnostic utility of pleural fluid ADA and interferon-gamma release assay (IGRA) in differentiating tubercular and non-tubercular exudative pleural effusion Source: International Congress 2015 – WHO guidelines in TB and clinical practice Year: 2015
Performance of a commercial whole blood interferon-gamma release assays in the management of pleural effusions Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009
Diagnostic value of interleukin-12 p40 in tuberculous pleural effusions Source: Eur Respir J 2009; 33: 816-820 Year: 2009
The value of interferon (IFN)-γ pleural effusion tests in diagnosis of tuberculosis Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease Year: 2007
Diagnostic significance of interferon-gamma level in tuberculous pleural effusions Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease and problems in tuberculosis care Year: 2007
Use of cytokines in the diagnosis and outcome correlation of tuberculous pleural effusion Source: Eur Respir J 2002; 20: Suppl. 38, 210s Year: 2002
Serial measurement of pleural fluid ADA in tuberculous pleurisy Source: Eur Respir J 2003; 22: Suppl. 45, 160s Year: 2003
Diagnostic performance of antigen induced IFN-? production in pleural fluid in tuberculous pleurisy Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019
Bactec versus histopathology in the clinical diagnosis of tuberculous pleural effusion Source: Eur Respir J 2001; 18: Suppl. 33, 472s Year: 2001
The clinical utility of interferon-γ release assay (IGRA) from pleural fluid in addition to IGRA from blood in patients with pleural effusion Source: Annual Congress 2010 - Extrapulmonary tuberculosis Year: 2010
Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021
Polarized cytokine profiles in the peripheral blood and pleural fluid from the patients with tuberculous pleurisy, pulmonary tuberculosis combined disease, and malignant pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 467s Year: 2004
The diagnostic value of interleukin-6 in distinguishing tuberculous pleurisy from malign effusion Source: Eur Respir J 2001; 18: Suppl. 33, 499s Year: 2001
Differential diagnosis of pleural effusion based upon the cytoanalysis of the pleural fluid Source: Eur Respir J 2006; 28: Suppl. 50, 455s Year: 2006
Diagnostic assessment in tuberculous pleural effusions Source: Eur Respir J 2005; 26: Suppl. 49, 413s Year: 2005
Accuracy of pleural fluid c-reactive protein in differentiating between tuberculous and malignant pleural effusions: a meta-analysis Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
T-cell interferon-γ release assay for the diagnosis of tuberculous pleuritis in routine clinical practice Source: Annual Congress 2007 - New methods to diagnose tuberculosis infection and disease Year: 2007
Pleural fluid IL-6 levels in the identification of the complicated parapneumonic pleural effusion Source: Annual Congress 2008 - Pleural effusion Year: 2008